State Of Alaska, Department Of Revenue Collegium Pharmaceutical, Inc Transaction History
State Of Alaska, Department Of Revenue
- $8.95 Billion
- Q4 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 18,274 shares of COLL stock, worth $570,148. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,274
Previous 18,384
0.6%
Holding current value
$570,148
Previous $710,000
26.34%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$181 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$73.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51.7 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...